Microenvironmental regulators of tissue structure and function also regulate tumor induction and progression: The role of extracellular matrix and its degrading enzymes

被引:215
作者
Bissell, M. J. [1 ]
Kenny, P. A. [1 ]
Radisky, D. C. [1 ]
机构
[1] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Dept Canc Biol, Div Life Sci, Berkeley, CA 94720 USA
来源
MOLECULAR APPROACHES TO CONTROLLING CANCER | 2005年 / 70卷
关键词
D O I
10.1101/sqb.2005.70.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
It is now widely accepted that elements of the cellular and tissue microenvironment are crucial regulators of cell behavior in culture and homeostasis in vivo, and that many of the same factors influence the course of tumor progression. Less well established is the extent to which extracellular factors actually cause cancer, and the circumstances under which this may occur. Using physiologically relevant three-dimensional culture assays and transgenic animals, we have explored how the environmental and architectural context of cells, tissues, and organs controls mammary-specific gene expression, growth regulation, apoptosis, and drug resistance and have found that loss of tissue structure is a prerequisite for cancer progression. Here we summarize this evidence and highlight two of our recent studies. Using mouse mammary epithelial cells, we show that exposure to matrix metalloproteinase-3 (MMP-3) stimulates production of reactive oxygen species (ROS) that destabilize the genome and induce epithelial-mesenchymal transition, causing malignant transformation. Using a human breast cancer progression series, we find that ADAM-dependent growth factor shedding plays a crucial role in acquisition of the malignant phenotype. These findings illustrate how normal tissue structure controls the response to extracellular signals so as to preserve tissue specificity and growth status.
引用
收藏
页码:343 / 356
页数:14
相关论文
共 137 条
  • [42] Gudjonsson T, 2002, J CELL SCI, V115, P39
  • [43] Ha HY, 2001, CANCER RES, V61, P984
  • [44] HARACH HR, 1985, CANCER-AM CANCER SOC, V56, P531, DOI 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO
  • [45] 2-3
  • [46] HAYASHI N, 1990, CANCER RES, V50, P4747
  • [47] Hefler LA, 2003, CANCER RES, V63, P3066
  • [48] Reprogramming of a melanoma genome by nuclear transplantation
    Hochedlinger, K
    Blelloch, R
    Brennan, C
    Yamada, Y
    Kim, MJ
    Chin, L
    Jaenisch, R
    [J]. GENES & DEVELOPMENT, 2004, 18 (15) : 1875 - 1885
  • [49] Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma
    Howell, WM
    Bateman, A
    Turner, SJ
    Collins, A
    Theaker, JM
    [J]. GENES AND IMMUNITY, 2002, 3 (04) : 229 - 232
  • [50] PP60V-SRC TYROSINE KINASE IS EXPRESSED AND ACTIVE IN SARCOMA-FREE AVIAN EMBRYOS MICROINJECTED WITH ROUS-SARCOMA VIRUS
    HOWLETT, AR
    CARTER, VC
    MARTIN, GS
    BISSELL, MJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (20) : 7587 - 7591